Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Atara Biotherap (NQ: ATRA )

13.83 USD -0.08 (-0.58%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 12, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 544,181
Open 13.71
Bid (Size) 12.62 (3)
Ask (Size) 14.92 (1)
Prev. Close 13.91
Today's Range 13.71 - 14.47
52wk Range 8.900 - 28.20
Shares Outstanding 84,076,737
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Atara Biotherapeutics Names Cell Therapy & Oncology Leader Cokey Nguyen, Ph.D. as Chief Scientific Officer
Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a pioneer in T-cell immunotherapy, leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with serious diseases... 
From Business Wire News Releases
Atara Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a pioneer in T-cell immunotherapy, leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with serious diseases... 
From Business Wire News Releases

Performance

YTD
-29.58%
-29.58%
1 Month
+0.95%
+0.95%
3 Month
-28.56%
-28.56%
6 Month
-12.13%
-12.13%
1 Year
+29.25%
+29.25%

More News

Read More
Atara Biotherapeutics Announces First Quarter 2021 Financial Results and Operational Progress
From Business Wire News Releases
Atara Biotherapeutics to Announce First Quarter 2021 Financial Results on Tuesday, May 4, 2021
From Business Wire News Releases
Atara Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
From Business Wire News Releases
Atara Biotherapeutics Presents New Long-Term Overall Survival Data from a Combined Analysis of Phase 2 Tab-cel® Studies for Epstein-Barr Virus-Driven Post-Transplant Lymphoproliferative Disease at The
From Business Wire News Releases
Atara Biotherapeutics to Participate in Virtual 33rd Annual ROTH Conference
From Business Wire News Releases
Atara Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
From Business Wire News Releases
Atara Biotherapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Operational Progress
From Business Wire News Releases
Atara Biotherapeutics to Announce Fourth Quarter and Full Year 2020 Financial Results on Monday, March 1, 2021
From Business Wire News Releases
Atara Biotherapeutics Inc (ATRA) Q1 2021 Earnings Call Transcript
Tags Market News ATRA
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.